Amph stock buy or sell

View the real-time AMPH price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Amphastar Pharmaceuticals against related stocks people have also bought like ACB, GE, CGC, and CRON. 521 people own Amphastar Pharmaceuticals on Robinhood on April 5, 2020. AMPH Stock | AMPHASTAR PHARMACEUTICALS Stock Price … AMPH: Get the latest Amphastar Pharmaceuticals stock price and detailed information including AMPH news, historical charts and realtime prices.

Exploring Amphastar Pharmaceuticals (NASDAQ:AMPH) stock? View AMPH's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or … AMPH Stock Price | Amphastar Pharmaceuticals Inc. Stock ... AMPH | Complete Amphastar Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, Quote ... Find the latest Amphastar Pharmaceuticals, Inc. (AMPH) stock quote, history, news and other vital information to help you with your stock trading and investing.

Amphastar Pharmaceuticals is a pharmaceutical company focused on developing, manufacturing, marketing and selling generic and injectable, inhalation, and 

Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to “Strong Sell” at BidaskClub; One analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. Amphastar Pharmaceuticals has a consensus … Insider Trading Alert - SCVL, AMPH And ROST Traded By ... Mar 22, 2016 · The stock currently has a dividend yield of 0.92%. The company has a P/E ratio of 23.3. Currently, there are 10 analysts who rate Ross Stores a buy, no analysts rate it a sell, and 7 rate it a hold. Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Rating ... BidaskClub cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) from a sell rating to a strong sell rating in a research report report published on Tuesday morning, BidAskClub reports.. AMPH has been the topic of a number of other reports. Needham & Company LLC reiterated a hold rating on shares of Amphastar Pharmaceuticals in a research note on Wednesday, January 29th. BidaskClub Upgrades Amphastar Pharmaceuticals … Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report issued on Friday, BidAskClub reports.

Mar 13, 2019 · Today, Amphastar Pharmaceuticals Inc AMPH, -0.62% stock was downgraded by Needham & Company LLC from Buy to Hold with a price target of $22.20. There are 3 Hold Ratings, 2 Buy Ratings, no Strong

Should I buy Amphastar Pharmaceuticals, Inc. (AMPH)? Use the Zacks Rank and Style Scores to find out is AMPH is right for your portfolio. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products  Exploring Amphastar Pharmaceuticals (NASDAQ:AMPH) stock? average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings. NASDAQ:AMPHAmphastar Pharmaceuticals Price Target & Analyst Ratings is $29.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy." Ratings Breakdown: 0 Sell Rating(s) 1 Hold  Find the latest Amphastar Pharmaceuticals, Inc. (AMPH) stock quote, history, news and 15.28-0.33 (-2.11%). As of April 7 1:07PM EDT. Market open. Buy. Sell. AMPH | Complete Amphastar Pharmaceuticals Inc. stock news by MarketWatch. Amphastar Pharmaceuticals downgraded to outperform from strong buy at  Amphastar Pharmaceuticals Inc (AMPH) Q4 2019 Earnings Call Transcript Mar 12, 2020 Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold manufacturing, marketing and selling technically challenging generic and  

Zacks Investment Research upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) from a hold rating to a buy rating in a report published on Friday, Zacks.com reports. They currently have $16.00 target price on the stock. According to Zacks, “Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company.

Insider Trade - Amph' Insider Stock Buys and Sells ... Insider Trade - Amph's Insider Stock Buys and Sells To find out why GuruFocus thinks data on insider trades is interesting, read. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In Amphastar Pharmaceuticals Stock Forecast: down to 12.522 ... Amphastar Pharmaceuticals, Inc () Stock Market infoRecommendations: Buy or sell Amphastar Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Amphastar Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Amphastar Pharmaceuticals's AMPH shares and potentially its market environment have Insider Selling: Amphastar Pharmaceuticals Inc (NASDAQ ...

Amphastar Pharmaceuticals Inc AMPH gets downgraded to Hold ...

All News for AMPH - Zacks Investment Research: Stock ... Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results. All News for AMPH : Amphastar Pharmaceuticals AMPH Stock Price Quote & News - Amphastar ... - Robinhood View the real-time AMPH price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Amphastar Pharmaceuticals against related stocks people have also bought like ACB, GE, CGC, and CRON. 521 people own Amphastar Pharmaceuticals on Robinhood on April 5, 2020. AMPH Stock | AMPHASTAR PHARMACEUTICALS Stock Price … AMPH: Get the latest Amphastar Pharmaceuticals stock price and detailed information including AMPH news, historical charts and realtime prices.

We cover the latest Amphastar P headlines and breaking news impacting Amphastar P stock performance. Amphastar P (AMPH) NASDAQ Symbol Exchange charts and buy/sell signals contained within Amphastar Pharmaceuticals (NASDAQ:AMPH) Lifted to “Buy” at ... Zacks Investment Research upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) from a hold rating to a buy rating in a report published on Friday, Zacks.com reports. They currently have $16.00 target price on the stock. According to Zacks, “Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. AMPH Stock Quote - Amphastar Pharmaceuticals, Inc. Stock ... AMPH stock quote, chart and news. Get Amphastar Pharmaceuticals, Inc.'s stock price today. » Buy AMPH Online Today!, find the best broker here. Bitcoin & Crypto Movers . Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and Amphastar Pharmaceuticals Inc AMPH gets downgraded to Hold ...